• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect . INFLUENZA HOUSEHOLD TRANSMISSION AND GENOMIC DIVERSITY IN THE UNITED STATES: A PROSPECTIVE COHORT STUDY, 2022-2024

tetano

Editor, Senior Moderator
J Infect


. 2026 Apr 20:106748.
doi: 10.1016/j.jinf.2026.106748. Online ahead of print.
INFLUENZA HOUSEHOLD TRANSMISSION AND GENOMIC DIVERSITY IN THE UNITED STATES: A PROSPECTIVE COHORT STUDY, 2022-2024

Sarah N Cox[SUP] 1 [/SUP], Julia C Bennett[SUP] 1 [/SUP], Amanda M Casto[SUP] 2 [/SUP], Katherine L Hoffman[SUP] 3 [/SUP], Collrane Frivold[SUP] 1 [/SUP], Marco Carone[SUP] 3 [/SUP], Zack Acker[SUP] 4 [/SUP], Tara M Babu[SUP] 2 [/SUP], Cassandra L Boisvert[SUP] 5 [/SUP], Brenna Ehmen[SUP] 4 [/SUP], Janet A Englund[SUP] 6 [/SUP], Sally Grindstaff[SUP] 4 [/SUP], Peter Han[SUP] 4 [/SUP], Tara L Hatchie[SUP] 2 [/SUP], Jennifer L Kuntz[SUP] 5 [/SUP], Christina M Lockwood[SUP] 7 [/SUP], Kathryn M McCaffrey[SUP] 4 [/SUP], Richard A Mularski[SUP] 5 [/SUP], Lani Regelbrugge[SUP] 4 [/SUP], Sacha Reich[SUP] 5 [/SUP], Mark A Schmidt[SUP] 5 [/SUP], Ning Smith[SUP] 5 [/SUP], Lea Starita[SUP] 8 [/SUP], Jeremy Stone[SUP] 4 [/SUP], Alexandra Varga[SUP] 5 [/SUP], Ana A Weil[SUP] 9 [/SUP], Allison L Naleway[SUP] 5 [/SUP], Helen Y Chu[SUP] 10 [/SUP]


Affiliations
Abstract

Objectives: To analyze the extent and risk factors of household influenza transmission using molecular testing and viral genomes.
Methods: In a community-based cohort in the United States during 2022- 2024, participants self-collected weekly nasal swabs. Swabs were tested for influenza by RT-PCR; genomic sequencing was performed. Index cases had the first influenza detection within households. Factors associated with household transmission were evaluated using Poisson regression.
Results: Influenza transmission was detected in 56/303 influenza-positive households with a distinct index case. Most (82%) index cases were symptomatic; 16% of children vs 28% of adults were asymptomatic. 89/941 household contacts were infected 1-7 days after the index (secondary household infection risk: 9.5%, 95% CI: 7.3, 12.2). Index and secondary case median ages were 11 and 24 years, respectively. A greater proportion of contacts were infected when the index case was symptomatic (11%) vs asymptomatic (5%). Higher viral load was associated with 3.1 (1.7, 5.8) times higher risk of secondary infection. Most (13/16) index-secondary case pairs with available sequences differed by ≤3 nucleotides.
Conclusions: Most household index cases were symptomatic children. Higher viral load and presence of symptoms among index cases were associated with household transmission. Home-based surveillance can assess household transmission using case chronology and genomics.

Keywords: adolescent; adult; community surveillance; epidemiology; genomics; household transmission; influenza; pediatric.

 
Back
Top